Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Eur J Haematol ; 105(1): 47-55, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32145118

ABSTRACT

INTRODUCTION: Clinical response and chemosensitivity of relapse or refractory AML patients were evaluated after rescue and bridge-to-transplant MEC (mitoxantrone, etoposide, and cytarabine) regimen. METHODS AND PATIENTS: Fifty-five consecutive AML patients were treated with MEC from 2009 to 2018. Chemosensitivity was evaluated by WT1 quantification. RESULTS: 27/55 patients (49.1%) had AML resistant to induction and 28/55 patients (50.9%) had AML relapse. 25/55 patients (45.5%) achieved a CR after one course of MEC, and 12 patients (21.8%) achieved WT1 negativity. In 12 patients, a second MEC was administered. Four out of 12 patients improved significantly their response with the 2nd MEC. MEC was an effective bridge to transplant, 32/55 patients (58.2%) received an allogenic stem cell transplant. Median overall survival (OS) from MEC was 455 days (95% CI 307-602 days.); patient with WT1 negative CR had the best OS (P<.000). CONCLUSION: WT1 is a useful marker of chemosensitivity after MEC as rescue and bridge-to-transplant therapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Leukemia, Myeloid, Acute/drug therapy , Preoperative Care , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cytarabine/adverse effects , Cytarabine/therapeutic use , Disease Management , Etoposide/adverse effects , Etoposide/therapeutic use , Hematopoietic Stem Cell Transplantation/methods , Humans , Induction Chemotherapy , Leukemia, Myeloid, Acute/diagnosis , Leukemia, Myeloid, Acute/etiology , Leukemia, Myeloid, Acute/mortality , Mitoxantrone/adverse effects , Mitoxantrone/therapeutic use , Prognosis , Recurrence , Treatment Outcome
2.
Assist Inferm Ric ; 32(3): 133-8, 2013.
Article in Italian | MEDLINE | ID: mdl-24158027

ABSTRACT

INTRODUCTION: Antisepsis of the skin of adults, children and newborns before the insertion of a peripheral venous catheter (PVC) reduces the risk of catheter related infections (CRI). Data on the effectiveness of electrolytic sodium hypochlorite are missing. METHODS: An explorative study was conducted on children, adults and newborns admitted to hospital and with skin antisepsis with sodium hypoclorite 0.057g with active chlorine 0.055g in 100ml (Amukine Med®) to assess the level of contamination of PVC tips, as surrogate sign of infection. Quantitative methods were used and the catheter tip was considered colonized if >1000 CFU (colony forming Units)/catheter segment. RESULTS: In the sample of 42 adults, 51 children and 52 newborns, 16.7%, 7.8% and 3.8% of catheter tips were contaminated respectively. No catheter related phlebites were observed. CONCLUSIONS: Skin antisepsis with Amukine Med® seems effective in preventing CRIs but further comparative studies are needed with the antiseptics recommended by guidelines.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Antisepsis/methods , Catheter-Related Infections/nursing , Catheterization, Peripheral/nursing , Skin/drug effects , Sodium Hypochlorite/administration & dosage , Administration, Cutaneous , Adult , Catheter-Related Infections/prevention & control , Child , Humans , Infant, Newborn , Intensive Care Units , Prospective Studies , Skin/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...